Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01451177 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)
A Phase 2 study, sponsored by Aderans Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT01451177 is a Phase 2 study that has completed, run by Aderans Research Institute. The registered enrollment target is 43 participants.
The verdict
NCT01451177, a Phase 2 study, has completed, sponsored by Aderans Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
Evaluate the injections of Ji Gami(TM) and Ji Gami(TM) DO, where cells are expanded ex vivo from scalp, to induce hair growth in male and female subjects with hair loss.
Interventions
- BIOLOGICAL Autologous cultured dermal and epidermal cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01451177
The ClinicalTrials.gov registry entry for NCT01451177 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aderans Research Institute, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Autologous cultured dermal and epidermal cells is the first listed.
NCT01451177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01451177 about?
NCT01451177 is a clinical study titled "A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)". Evaluate the injections of Ji Gami(TM) and Ji Gami(TM) DO, where cells are expanded ex vivo from scalp, to induce hair growth in male and female subjects with hair loss.
What is the current status of trial NCT01451177?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2010-05.
What interventions are being tested in trial NCT01451177?
The interventions under investigation include: Autologous cultured dermal and epidermal cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT01451177?
This trial is sponsored by Aderans Research Institute, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.